AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Immunome Inc. Director's Dealing 2021

Apr 6, 2021

32238_dirs_2021-04-05_1bd366f7-374c-45f6-ad86-10aa02acca88.zip

Director's Dealing

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Immunome Inc. (IMNM)
CIK: 0001472012
Period of Report: 2020-10-26

Reporting Person: Stoneman Sandra G. (Chief Legal Officer & Gen Coun)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5555	Direct